Cognitive Behavioral Therapy for Anxiety in Children with Autism and Intellectual Disability
(FYF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a therapy program called Facing Your Fears, designed to help children with autism and intellectual disabilities manage anxiety. The study tests the effectiveness of this therapy for children aged 12-18 who have both autism and significant anxiety. Participants will attend weekly sessions with their parents over two 12-week cycles to learn coping strategies. Children with autism who frequently experience anxiety symptoms might be a good fit for this trial. As an unphased trial, this study offers a unique opportunity for participants to contribute to developing effective anxiety management strategies for children with autism.
What prior data suggests that the Facing Your Fears intervention is safe for children with ASD and intellectual disability?
Research has shown that the Facing Your Fears program is generally well-received by children with autism. In various studies, children and teens with autism who participated in the program experienced noticeable reductions in anxiety. For instance, one study with 49 children found that Cognitive Behavioral Therapy (CBT) reduced anxiety in about 30% of them. Importantly, no major negative effects were reported, indicating that children managed the therapy well.
These studies suggest that the Facing Your Fears program is safe and can help reduce anxiety in children with autism. Although limited research exists specifically on children with both autism and intellectual disabilities, the existing evidence supports the program's safety in similar groups.12345Why are researchers excited about this trial?
Researchers are excited about the Facing Your Fears treatment because it adapts cognitive behavioral therapy (CBT) specifically for children with autism spectrum disorder (ASD) and intellectual disability, a group often underserved by standard anxiety treatments. While typical CBT approaches focus on emotional regulation and cognitive tools, this treatment fine-tunes those strategies to fit the unique sensory and regulatory profiles of these children. It also emphasizes gradual exposure to anxiety-inducing situations, providing a supportive and tailored environment for each child's needs. This specialized approach aims to offer more effective anxiety management for children who might not benefit from conventional methods.
What evidence suggests that the Facing Your Fears program might be an effective treatment for anxiety in children with autism and intellectual disability?
Research has shown that the Facing Your Fears (FYF) program, which participants in this trial may receive, helps reduce anxiety in autistic children and teens. Studies have found that participants experience a noticeable drop in anxiety levels after completing the FYF program. This program is especially helpful for autistic youth with anxiety disorders. FYF uses a form of therapy called cognitive-behavioral therapy (CBT) adapted for them. It teaches skills like managing emotions, thinking positively, and coping with stress. These skills help children deal with anxiety more effectively.13678
Are You a Good Fit for This Trial?
This trial is for children aged 12-18 with Autism Spectrum Disorder (ASD) and Intellectual Disability (ID), who also experience anxiety. They must meet the DSM-V criteria for ASD. The study seeks parent-child dyads, implying active parental involvement.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Facing Your Fears CBT intervention for anxiety in children with ASD and intellectual disability
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Facing Your Fears
Find a Clinic Near You
Who Is Running the Clinical Trial?
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor